
Oxford Immunotec Global PLC OXFD
Oxford Immunotec Global PLC P/B Ratio 2011-2026 | OXFD
Annual P/B Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 1.97 | 1.73 | 3.18 | 4.05 | 2.73 | 3.36 | 0.976 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.05 | 0.976 | 2.57 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 1.29 | -21.17 % | $ 1.72 M | ||
|
Agilent Technologies
A
|
7.78 | $ 111.7 | -1.36 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
1 | $ 19.13 | 1.32 % | $ 555 M | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 15.7 | -3.03 % | $ 475 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
2.6 | $ 142.54 | -0.49 % | $ 22.7 B | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.76 | -2.22 % | $ 7.79 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 19.97 | -2.54 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 93.91 | -2.86 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 415.27 | -0.93 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 031.64 | -0.99 % | $ 21.3 B | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 3.58 | -1.1 % | $ 332 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
1.77 | $ 8.24 | -1.44 % | $ 1.06 B | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
22.5 | $ 18.62 | -1.64 % | $ 417 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 150.85 | -5.3 % | $ 7.48 B | ||
|
Natera
NTRA
|
7.52 | $ 186.36 | -5.36 % | $ 18.3 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
2.76 | $ 25.23 | -1.06 % | $ 23.9 B | ||
|
Guardant Health
GH
|
-135 | $ 94.92 | -3.79 % | $ 11.9 B | ||
|
Personalis
PSNL
|
1.65 | $ 6.36 | -5.22 % | $ 568 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 116.38 | -0.61 % | $ 9.6 B | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 5.77 | -0.86 % | $ 241 M | ||
|
Soleno Therapeutics
SLNO
|
4.63 | $ 53.01 | 0.04 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.34 | -2.9 % | $ 5.38 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 250.4 | -1.43 % | $ 20.8 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 438.34 | -2.2 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
-5.51 | $ 0.57 | -1.59 % | $ 205 M | ||
|
Celcuity
CELC
|
53.4 | $ 137.68 | 2.2 % | $ 6.44 B | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 49.17 | -7.14 % | $ 2.94 B | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 8.19 | -2.85 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 186.61 | -0.71 % | $ 20.7 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M |